Author:
Kumar Ajay,Yang Enzhi,Du Yiqin
Reference21 articles.
1. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90(3):262–267. https://doi.org/10.1136/bjo.2005.081224
2. Du Y, Roh DS, Mann MM, Funderburgh ML, Funderburgh JL, Schuman JS (2012) Multipotent stem cells from trabecular meshwork become phagocytic TM cells. Invest Ophthalmol Vis Sci 53(3):1566–1575. https://doi.org/10.1167/iovs.11-9134
3. Du Y, Yun H, Yang E, Schuman JS (2013) Stem cells from trabecular meshwork home to TM tissue in vivo. Invest Ophthalmol Vis Sci 54(2):1450–1459. https://doi.org/10.1167/iovs.12-11056
4. Kumar A, Gandhi K, Du Y (2021) Trabecular meshwork regeneration by stem cells for glaucoma treatment: rationale, feasibility, and mechanisms. In: Samples J, Knepper P (eds) Glaucoma research and clinical advances, vol 2020–2022. Kugler Publications, pp 95–104
5. Yun H, Wang Y, Zhou Y, Wang K, Sun M, Stolz DB, Xia X, Ethier CR, Du Y (2018) Human stem cells home to and repair laser-damaged trabecular meshwork in a mouse model. Commun Biol 1:216. https://doi.org/10.1038/s42003-018-0227-z